Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia.
Cellular oncology (Dordrecht)（2023）
摘要
Our results highlight NCL as a prognostic marker in B-ALL and a potential therapeutic target to combat chemotherapy resistance in ALL.
更多查看译文
关键词
Acute lymphoblastic leukemia, Nucleolin, Resistance, ERK signaling, AS1411
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要